These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 3011620
1. [Effects of misoprostol, (+/-)-methyl (11 alpha, 13E)-11, 16-dihydroxy-16-methyl-9-oxoprost-13-en-l-oate, on various gastric and duodenal lesions in rats]. Okabe S, Takeuchi K, Ueki S, Inoue Y, Sunamoto M. Nihon Yakurigaku Zasshi; 1986 Mar; 87(3):339-50. PubMed ID: 3011620 [Abstract] [Full Text] [Related]
2. [Effects of KT1-32 on acute gastric lesions and duodenal ulcers induced in rats]. Okabe S, Takeuchi K, Mori Y, Furukawa O, Yamada Y. Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):467-76. PubMed ID: 3030907 [Abstract] [Full Text] [Related]
3. [Effects of elcatonin, a synthetic analogue of eel calcitonin, on acute gastric and duodenal lesions and gastroduodenal function in rats]. Takeuchi K, Furukawa O, Tanaka H, Nishiwaki H, Okabe S. Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):123-33. PubMed ID: 3699626 [Abstract] [Full Text] [Related]
4. Stimulation of duodenal bicarbonate secretion by misoprostol. Smedfors B, Johansson C. Dig Dis Sci; 1986 Feb; 31(2 Suppl):96S-100S. PubMed ID: 3080297 [Abstract] [Full Text] [Related]
5. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine]. Okabe S, Narita M, Nakaji S, Takinami Y, Kawano O, Misaki N. Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631 [Abstract] [Full Text] [Related]
6. Effects of MCI-727, a new antiulcer agent, on various gastric and duodenal lesions in experimental animals. Yamazaki S, Kawamura M, Kitsukawa M, Ando K, Nitta I, Tobe A, Okabe S. Jpn J Pharmacol; 1991 Apr; 55(4):415-24. PubMed ID: 1886287 [Abstract] [Full Text] [Related]
7. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, Rubin A. Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266 [Abstract] [Full Text] [Related]
8. The therapeutic efficacy of misoprostol in peptic ulcer disease. Watkinson G, Hopkins A, Akbar FA. Postgrad Med J; 1988 Aug; 64 Suppl 1():60-77. PubMed ID: 3138682 [Abstract] [Full Text] [Related]
9. Efficacy of prostanoids in the treatment of gastric ulcer. Rachmilewitz D. Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800 [Abstract] [Full Text] [Related]
10. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study. Jiranek GC, Kimmey MB, Saunders DR, Willson RA, Shanahan W, Silverstein FE. Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):656-61. PubMed ID: 2491827 [Abstract] [Full Text] [Related]
12. Effects of misoprostol, cimetidine, and ethanol on rat gastric plasma volume and morphology. Lacy ER, Hund P, Tietge J. J Clin Gastroenterol; 1990 Feb; 12 Suppl 1():S158-69. PubMed ID: 2120322 [Abstract] [Full Text] [Related]
13. A new model of duodenal ulcers induced in rats by indomethacin plus histamine. Takeuchi K, Furukawa O, Tanaka H, Okabe S. Gastroenterology; 1986 Mar; 90(3):636-45. PubMed ID: 3943695 [Abstract] [Full Text] [Related]
14. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats. Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamato T, Ito H, Yamano M, Nagakura Y, Miyata K. J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178 [Abstract] [Full Text] [Related]
15. Induction of duodenal ulcers in rats under water-immersion stress conditions. Influence of stress on gastric acid and duodenal alkaline secretion. Takeuchi K, Furukawa O, Okabe S. Gastroenterology; 1986 Sep; 91(3):554-63. PubMed ID: 3732762 [Abstract] [Full Text] [Related]
16. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester. Roszkowski AP, Garay GL, Baker S, Schuler M, Carter H. J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537 [Abstract] [Full Text] [Related]
17. Effects of absolute ethanol, misoprostol, cimetidine, and phosphate buffer on the morphology of rat gastric mucosae. Lacy ER. Dig Dis Sci; 1986 Feb; 31(2 Suppl):101S-107S. PubMed ID: 3080279 [Abstract] [Full Text] [Related]
18. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats. Sekiguchi H, Hamada K, Taga F, Nishino K. Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133 [Abstract] [Full Text] [Related]
19. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers. Asano M, Kurebayashi Y, Ryokawa Y, Hashizume T, Akashi A. Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535 [Abstract] [Full Text] [Related]
20. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats. Tanaka T, Bickel M, Herling AW, Sakurai M, Goto M, Hayashi S. Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]